UCB

TK2d Patient Journey Lead (Germany)

Stellenbeschreibung:

Overview

We are looking for a TK2d Patient Journey Lead who is proactive, scientifically proficient, and empathetic to join us in our Rare & Epilepsy Organization team, based in Monheim, Germany.

About the role:

You will play a pivotal role in ensuring that our innovative treatment reaches the patients who need it most, positively impacting the lives of those suffering from TK2d. Reporting directly to the EU TK2d Head and collaborating with a cross-functional team, you will support the identification, proper diagnosis, and treatment for TK2d patients.

What you’ll do:

  • Partner with healthcare stakeholders to ensure TK2d patients are diagnosed and receive appropriate treatment.
  • Execute disease awareness and educational programs.
  • Establish referral programs to facilitate patients are consulted at centers of excellence.
  • Advocate for TK2d inclusion in mitochondrial and neuromuscular panels.
  • Map Patients Journeys to understand patient pain points and how to mitigate them.
  • Interactions with Patient Associations for patient awareness and educational initiatives.
  • Local point of contact supporting the implementation of approved Access+ programs.
  • Help healthcare providers navigate the ecosystem to secure funding for patients.
  • Ensure smooth transition from clinical trials and Access + programs to continuous treatment.
  • Educate healthcare providers and payors on the safe use of the available treatment.
  • Support patients through centrally developed patient support programs.

Qualifications

  • Bachelor’s degree in life sciences, business, or healthcare required; Master’s degree preferred.
  • University degree in medicine, pharmacy, or natural sciences.
  • 7+ years in biotechnology/pharmaceuticals with external engagement experience.
  • 5+ years in reimbursement, account management, or KOL development.
  • Experience in rare diseases, neurology, clinical genetics, or metabolic diseases.
  • Strong project management and planning skills, and emotional intelligence.
  • Outcome-driven with a focus on delivering results and fostering collaboration and communication.
  • Field-based position with up to 70% travel required.
  • Excellent presentation and interpersonal skills.
  • Proficiency in English and German.

Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!

About Us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are around 8,500 people in all four corners of the globe, inspired by patients and driven by science.

Equal opportunity employer. UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.

#J-18808-Ljbffr
NOTE / HINWEIS:
EnglishEN: Please refer to Fuchsjobs for the source of your application
DeutschDE: Bitte erwähne Fuchsjobs, als Quelle Deiner Bewerbung

Stelleninformationen

  • Veröffentlichungsdatum:

    05 Mai 2026
  • Gehaltsspanne (KI-Schätzung):

    60000€ bis 90000€ p.a.
  • Standort:

    Mettmann

    Einsatzort:

    Monheim
  • Typ:

    Vollzeit
  • Arbeitsmodell:

    Vor Ort
  • Kategorie:

    Development & IT
  • Erfahrung:

    Senior
  • Arbeitsverhältnis:

    Angestellt

KI Suchagent

AI job search

Möchtest über ähnliche Jobs informiert werden? Dann beauftrage jetzt den Fuchsjobs KI Suchagenten!

Diese Jobs passen zu Deiner Suche:

partner ad:Stepstone partner
Vollzeit Heidelberg
13 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Trier
15 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Mailand
15 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Unterföhring
15 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Europaweit
15 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Mannheim
15 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Trier
15 Mai 2026Development & IT
partner ad:Stepstone partner
Vollzeit Berlin
15 Mai 2026Development & IT